These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38637476)

  • 1. ERBB2 Targeting Reveals a Significant Suppression of Tumorigenesis in Murine Endometrial Cancer with Pten Mutation.
    Dunston K; Hunter MI; Johannesen E; Jung JS; Kim TH; Yoo JY; Jeong JW
    Reprod Sci; 2024 Aug; 31(8):2458-2467. PubMed ID: 38637476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression.
    Kim TH; Franco HL; Jung SY; Qin J; Broaddus RR; Lydon JP; Jeong JW
    Oncogene; 2010 Jul; 29(26):3770-80. PubMed ID: 20418913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
    Kim TH; Yoo JY; Kim HI; Gilbert J; Ku BJ; Li J; Mills GB; Broaddus RR; Lydon JP; Lim JM; Yoon HG; Jeong JW
    Cancer Res; 2014 Dec; 74(24):7371-82. PubMed ID: 25377472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Generation and comparison of two genetically engineered mouse models of ErbB2/Neu positive-PTEN deficient breast cancer].
    Wang QF; Ding H; Liu BR; Zhang K
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 43(4):427-33. PubMed ID: 25187457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.
    Gao Y; Lin P; Lydon JP; Li Q
    J Pathol; 2017 Sep; 243(1):89-99. PubMed ID: 28657664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias.
    Dosil MA; Mirantes C; Eritja N; Felip I; Navaridas R; Gatius S; Santacana M; Colàs E; Moiola C; Schoenenberger JA; Encinas M; Garí E; Matias-Guiu X; Dolcet X
    J Pathol; 2017 Jun; 242(2):152-164. PubMed ID: 28349562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma.
    Konopka B; Janiec-Jankowska A; Paszko Z; Goluda M
    J Cancer Res Clin Oncol; 2004 Feb; 130(2):114-21. PubMed ID: 14663583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARG1 Is a Potential Prognostic Marker in Metastatic Endometrial Cancer.
    Tran DN; Rozen V; Nguyen LTK; Jung JS; Coghill LM; Hunter MI; Kim TH; Yoo JY; Jeong JW
    Reprod Sci; 2024 Jun; 31(6):1632-1641. PubMed ID: 38388922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of ω-3 Polyunsaturated Fatty Acids Attenuates PTEN-deficiency Induced Endometrial Cancer Development through Regulation of COX-2 and PGE2 Production.
    Pan J; Cheng L; Bi X; Zhang X; Liu S; Bai X; Li F; Zhao AZ
    Sci Rep; 2015 Oct; 5():14958. PubMed ID: 26468779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten.
    Liang X; Daikoku T; Terakawa J; Ogawa Y; Joshi AR; Ellenson LH; Sun X; Dey SK
    PLoS Genet; 2018 Aug; 14(8):e1007630. PubMed ID: 30142194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial tumorigenesis in Pten(+/-) mice is independent of coexistence of estrogen and estrogen receptor α.
    Joshi A; Wang H; Jiang G; Douglas W; Chan JS; Korach KS; Ellenson LH
    Am J Pathol; 2012 Jun; 180(6):2536-47. PubMed ID: 22503752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA OIP5-AS1 Suppresses Cell Proliferation and Invasion of Endometrial Cancer by Regulating PTEN/AKT via Sponging miR-200c-3p.
    Liu Y; Cai X; Cai Y; Chang Y
    J Immunol Res; 2021; 2021():4861749. PubMed ID: 34368370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice.
    Begum M; Tashiro H; Katabuchi H; Suzuki A; Kurman RJ; Okamura H
    Lab Invest; 2006 Mar; 86(3):286-96. PubMed ID: 16402032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy.
    Bian X; Gao J; Luo F; Rui C; Zheng T; Wang D; Wang Y; Roberts TM; Liu P; Zhao JJ; Cheng H
    Oncogene; 2018 Jan; 37(3):341-351. PubMed ID: 28945226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations in endometrial cancer by targeted next-generation sequencing.
    Chang YS; Huang HD; Yeh KT; Chang JG
    Exp Mol Pathol; 2016 Feb; 100(1):8-12. PubMed ID: 26626801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of genetic alterations in human endometrial cancer and melanoma: distinct tumorigenic pathways that share a frequent abnormal PI3K/AKT cascade.
    Ogawa K; Sun C; Horii A
    Oncol Rep; 2005 Dec; 14(6):1481-5. PubMed ID: 16273242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutual contribution of Pten and estrogen to endometrial carcinogenesis in a PtenloxP/loxP mouse model.
    Saito F; Tashiro H; To Y; Ohtake H; Ohba T; Suzuki A; Katabuchi H
    Int J Gynecol Cancer; 2011 Nov; 21(8):1343-9. PubMed ID: 21989218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sensitivity of human endometrial carcinoma cells with different PTEN expression to mitogen-activated protein kinase signaling inhibits and implications for therapy.
    Xiao L; Yang YB; Li XM; Xu CF; Li T; Wang XY
    J Cancer Res Clin Oncol; 2010 Jul; 136(7):1089-99. PubMed ID: 20087603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines.
    Qu W; Zhao Y; Wang X; Qi Y; Zhou C; Hua Y; Hou J; Jiang SW
    Clin Chim Acta; 2019 Feb; 489():225-232. PubMed ID: 30107158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of MIG-6 results in endometrial progesterone resistance via ERBB2.
    Yoo JY; Kim TH; Shin JH; Marquardt RM; Müller U; Fazleabas AT; Young SL; Lessey BA; Yoon HG; Jeong JW
    Nat Commun; 2022 Mar; 13(1):1101. PubMed ID: 35232969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.